-
Oct 08, 2019
With most of the 2019 state legislative sessions complete, state lawmakers are beginning to look toward legislative priorities for 2020, including new drug pricing legislation.
Full story
-
Sep 17, 2019
Strong bipartisan support from the powerful Senate Finance Committee indicates that DIR fee reform remains a priority issue in the ongoing drug pricing debate.
Full story
-
Aug 14, 2019
The National Community Pharmacists Association (NCPA) recently issued a call to action to urge pharmacists to ask U.S. Senators on the Senate Finance Committee to sign onto a bipartisan letter addressed to HHS and CMS asking the Administration to revive DIR fee reform for plan year 2021. Take action immediately and urge your Senator to join their committee colleagues as a signatory on this letter.
Full story
-
Jul 26, 2019
Full story
-
Jul 26, 2019
Full story
-
Jul 26, 2019
Full story
-
Jun 17, 2019
Nightengale, President of Good Neighbor Pharmacy, wrote to the Chairman and Ranking Member of the Senate Finance Committee urging inclusion of the Phair Pricing Act in the Committee's drug pricing package.
Full story
-
May 29, 2019
Contact your Senators and urge them to sign onto a bipartisan letter being led by community pharmacy champions Senators Shelley Moore Capito (R-W.Va.) and Jon Tester (D-Mont.).
Full story
-
May 24, 2019
Let your legislators know you support for DIR reform and ask them to do the same!
Full story
-
May 20, 2019
AmerisourceBergen supports policies that lower out-of-pocket costs for patients and stands ready to support a transition to a patient-centered model with distributors serving as chargeback administrators for a January 1, 2020 start.
Full story